The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer

被引:53
|
作者
Xiong, Guangbing [1 ,2 ]
Feng, Mengyu [1 ,2 ]
Yang, Gang [1 ,2 ]
Zheng, Suli [1 ,2 ]
Song, Xujun [1 ,2 ]
Cao, Zhe [1 ,2 ]
You, Lei [1 ,2 ]
Zheng, Lianfang [2 ,3 ]
Hu, Ya [1 ,2 ]
Zhang, Taiping [1 ,2 ]
Zhao, Yupei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Pancreatic cancer; Chemoresistance; microRNA; Long non-coding RNA; Mechanism; PREDICTS POOR-PROGNOSIS; GEMCITABINE RESISTANCE; DUCTAL ADENOCARCINOMA; DOWN-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; GASTRIC-CANCER; UP-REGULATION; INCREASES CHEMORESISTANCE; RIBONUCLEOTIDE REDUCTASE;
D O I
10.1016/j.canlet.2017.02.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer, which is often asymptomatic, is currently one of the most common causes of cancer related death. This phenomenon is most likely due to a lack of early diagnosis, a high metastasis rate and a disappointing chemotherapy outcome. Thus, improving treatment outcomes by overcoming chemotherapy resistance may be a useful strategy in pancreatic cancer. Various underlying mechanisms involved in the chemoresistance of pancreatic cancer have been investigated. Notably, non-coding RNAs (ncRNAs), especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play a pivotal role in regulating sensitivity to chemotherapy in pancreatic cancer. In this review, we highlight recent evidence regarding the role of miRNAs and IncRNAs in the chemoresistance of pancreatic cancer, including their expression levels, targets, biological functions and the regulation of chemoresistance, and discuss the potential clinical application of miRNAs and IncRNAs in the treatment of pancreatic cancer. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 102
页数:9
相关论文
共 50 条
  • [31] Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
    Gong, Ruining
    Jiang, Yueping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs
    Sarfraz, Muhammad
    Abida
    Eltaib, Lina
    Asdaq, Syed Mohammed Basheeruddin
    Guetat, Arbi
    Alzahrani, A. Khuzaim
    Alanazi, Shatha Sulaiman
    Aaghaz, Shams
    Singla, Neelam
    Imran, Mohd
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 255
  • [33] Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
    Eptaminitaki, Giasemi C.
    Stellas, Dimitris
    Bonavida, Benjamin
    Baritaki, Stavroula
    DRUG RESISTANCE UPDATES, 2022, 65
  • [34] Navigating the labyrinth of long non-coding RNAs in colorectal cancer: From chemoresistance to autophagy
    Yu, Jia-Mei
    Sun, Chong-Qi
    Xu, Huan-Huan
    Jiang, Ya-Li
    Jiang, Xing-Yu
    Ni, Si-Qi
    Zhao, Ting-Yu
    Liu, Ling-Xiang
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (08)
  • [35] Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer
    Yan, Shushan
    Wang, Shufeng
    Wang, Xinyi
    Dai, Wenqing
    Chu, Jinjin
    Cheng, Min
    Guo, Zhiliang
    Xu, Donghua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review
    Dehghanian, Fariba
    Azhir, Zahra
    Khalilian, Sheyda
    Gruening, Bjoern
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) : 405 - 428
  • [37] Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer
    Robless, Eunice Eugenia
    Howard, Justin Andrew
    Casari, Ilaria
    Falasca, Marco
    CANCER LETTERS, 2021, 501 : 55 - 65
  • [38] Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
    Taucher, V.
    Mangge, H.
    Haybaeck, J.
    CELLULAR ONCOLOGY, 2016, 39 (04) : 295 - 318
  • [39] Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
    V. Taucher
    H. Mangge
    J. Haybaeck
    Cellular Oncology, 2016, 39 : 295 - 318
  • [40] Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
    Sempere, Lorenzo F.
    Powell, Katherine
    Rana, Jatin
    Brock, Andrew A.
    Schmittgen, Thomas D.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (03) : 761 - 776